Healthcare News and Research

Latest Healthcare News and Research

New data validates use of ActiveCare DVT prophylaxis compression system following total joint replacement surgery

Medical Compression Systems, Inc. (MCS), today announced new data further validating the use of the ActiveCare DVT prophylaxis compression system following total joint replacement procedures.

11 Nov 2015

Vitamin D deficiency puts people at risk of developing heart problems

A lack of vitamin D can result in weak bones. Recent studies also show that vitamin D deficiency is linked to more serious health risks such as coronary artery disease, heart attacks, and strokes.

10 Nov 2015

Purple Button mobile app helps HMC achieve overall goal of improving patient safety, quality

CRG Medical officially announced today the implementation of the ONC for IT award winning Purple Button mobile patient safety application at HMC. The Purple Button, powered by CRG Medical, supports the KB Core High Reliability Patient Safety Evaluation System and has been instrumental in assisting HMC toward their overall goal of improving patient safety, quality and satisfaction.

10 Nov 2015

SKYGEN USA announces launch of Hylis Pharmacy Solutions

Citing a need to bring skyrocketing pharmacy costs under control, SKYGEN USA, the umbrella brand for a distinguished family of benefit management companies and technology solutions for health payers and healthcare organizations, today announced the launch of Hylis Pharmacy Solutions.

10 Nov 2015

Boston Children's and Rock Health team up to accelerate development of pediatric health technologies

Boston Children's Hospital and digital health venture fund Rock Health today announced a strategic partnership aimed at accelerating the development of pediatric health technologies. Detailed today during Boston Children's Hospital's Global Pediatric Innovation Summit + Awards (#PedInno15), the partnership will foster the development of digital tools and devices to improve pediatric care.

10 Nov 2015

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Boston Scientific has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies.

10 Nov 2015

Perrigo receives FDA approval for generic version of KlorCon extended-release tablets

Perrigo Company plc today announced it has received an AB therapeutic equivalent rating and final U.S. Food and Drug Administration approval for the generic version of KlorCon extended-release tablets (600 mg and 750 mg), manufactured by Upsher-Smith Laboratories, Inc., and marketed by Sandoz Pharmaceuticals, Inc.

10 Nov 2015

Interventional Spine receives FDA clearance for Opticage Expandable Interbody Fusion Device

Interventional Spine, Inc. today announced the FDA clearance of their next generation Opticage Expandable Interbody Fusion Device. The next generation system is an enhanced version of the original Opticage system that was introduced in 2012.

10 Nov 2015

HSS researchers help identify lupus patients at increased risk of problem pregnancies

For years doctors have been advising patients with lupus not to get pregnant. It was assumed that the likelihood of pregnancy complications was too high in this population. However, ongoing work by researchers at Hospital for Special Surgery is helping identify those lupus patients who are - and aren't - at increased risk of problem pregnancies.

10 Nov 2015

PAREXEL expands market access and clinical evidence services

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced expanded evidence-based services for biopharmaceutical products.

10 Nov 2015

European regulator concludes that evidence does not support a causal relationship between human papillomavirus vaccines and CRPS or POTS

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has completed a detailed scientific review of the evidence surrounding reports of two syndromes, complex regional pain syndrome (CRPS) and postural orthostatic tachycardia syndrome (POTS) in young women given human papillomavirus (HPV) vaccines.

10 Nov 2015

New Cleveland Clinic study shows bariatric surgery is safe option for managing type 2 diabetes in overweight or mildly obese patients

Weight-loss surgery, long considered a treatment largely reserved for people with severe obesity, may also be a good and safe option for the treatment of uncontrolled type 2 diabetes in those who are overweight or have mild to moderate obesity, according to researchers from Cleveland Clinic in Ohio.

10 Nov 2015

Gastric balloon in a pill helps patients lose weight without surgery or endoscopy

A new gastric balloon that can be swallowed like a pill and then filled while in the stomach, helped patients lose more than 37 percent of their excess weight over four months, according to new research presented here at ObesityWeek 2015, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The weeklong conference is hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society (TOS).

10 Nov 2015

Astellas enters into definitive agreement to acquire Ocata

Astellas Pharma Inc. and Ocata Therapeutics, Inc., a biotechnology company focused on the research and development of new therapies in the field of regenerative medicine, primarily cell therapy addressing unmet medical needs in ophthalmology patients, announced today that they have entered into a definitive agreement.

10 Nov 2015

Obesity groups take aim at states that deny coverage of obesity treatment under affordable care act

The American Society for Metabolic and Bariatric Surgery (ASMBS) and groups including The Obesity Society (TOS) and Academy for Nutrition and Dietetics (AND), filed a complaint this month with U.S. Health and Human Services (HHS) claiming the 27 states that deny coverage for bariatric surgery are in non-compliance with the Affordable Care Act (ACA) and that their failure to comply is discriminatory against women and people with disabilities, and violates the ban against denying coverage based on health status or a pre-existing condition.

10 Nov 2015

Paratek initiates Omadacycline phase 3 clinical study in community acquired bacterial pneumonia (CABP)

Paratek Pharmaceuticals, Inc. has announced the dosing of the first patient in its Phase 3 clinical study of its lead drug candidate, omadacycline, for the treatment of Community Acquired Bacterial Pneumonia (CABP). This global Phase 3 study will assess the efficacy and safety of omadacycline compared with moxifloxacin in subjects with CABP.

9 Nov 2015

Armaron Bio starts Phase 2 trial for novel lead candidate drug for heart failure

Armaron Bio, a Melbourne-based drug development company focused on heart failure and other diseases, is pleased to announce that it has begun its Phase II clinical trial for NP202, its novel lead candidate drug for heart failure.

9 Nov 2015

WHO praises Sierra Leone for stopping Ebola transmission

The World Health Organization declares that Ebola virus transmission has been stopped in Sierra Leone. Forty-two days, that is two Ebola virus incubation cycles, have now passed since the last person confirmed to have Ebola virus disease had a second negative blood test.

9 Nov 2015

HIFU Prostate Services announces groundbreaking partnerships to offer prostate cancer treatments

HIFU Prostate Services, LLC, a leading provider of minimally-invasive prostate cancer treatment using High Intensity Focused Ultrasound ("HIFU"), announces groundbreaking partnerships with Michael J. Lazar, MD in Santa Rosa, Calif. and John H. Jurige, MD in Louisville, Ky., to offer HIFU treatments for prostate cancer.

9 Nov 2015

Nightstar announces $35 million Series B financing round

NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates, one of the world's leading venture capital firms.

9 Nov 2015

Healthcare News and Research

Latest Healthcare News and Research

New data validates use of ActiveCare DVT prophylaxis compression system following total joint replacement surgery

Vitamin D deficiency puts people at risk of developing heart problems

Purple Button mobile app helps HMC achieve overall goal of improving patient safety, quality

SKYGEN USA announces launch of Hylis Pharmacy Solutions

Boston Children's and Rock Health team up to accelerate development of pediatric health technologies

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Perrigo receives FDA approval for generic version of KlorCon extended-release tablets

Interventional Spine receives FDA clearance for Opticage Expandable Interbody Fusion Device

HSS researchers help identify lupus patients at increased risk of problem pregnancies

PAREXEL expands market access and clinical evidence services

European regulator concludes that evidence does not support a causal relationship between human papillomavirus vaccines and CRPS or POTS

New Cleveland Clinic study shows bariatric surgery is safe option for managing type 2 diabetes in overweight or mildly obese patients

Gastric balloon in a pill helps patients lose weight without surgery or endoscopy

Astellas enters into definitive agreement to acquire Ocata

Obesity groups take aim at states that deny coverage of obesity treatment under affordable care act

Paratek initiates Omadacycline phase 3 clinical study in community acquired bacterial pneumonia (CABP)

Armaron Bio starts Phase 2 trial for novel lead candidate drug for heart failure

WHO praises Sierra Leone for stopping Ebola transmission

HIFU Prostate Services announces groundbreaking partnerships to offer prostate cancer treatments

Nightstar announces $35 million Series B financing round

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in